Safely develop SARS-CoV-2 vaccines and antivirals using lentiviral particles pseudotyped with the N501Y Spike protein variant found in mouse-adapted virus.

  • Based on SBI’s popular and highly cited pPACKH1 Packaging System
  • Uses codon-optimized SARS-CoV-2 N501Y “S” protein in place of VSV-G envelope protein
  • Ideal for vaccine and antiviral efficacy studies under BSL2 conditions
  • Package any 3rd-generation lentivector reporter of your choice, including SBI’s popular LentiLabeler reporters
  • Use with pPACK-BALD, an envelope protein-free lentivector packaging system that is an ideal negative control
CVD19-560A-1pPACK-SPIKE N501Y, SARS-CoV-2 “S” Pseudotype – N501Y Mutant – Lentivector Packaging Mix10 Reactions
CVD19-570A-1pPACK-SPIKE N501Y, SARS-CoV-2 “S” Pseudotype – N501Y Mutant – Lentivector Packaging Mix (XL)25 Reactions
CVD19-575A-KITpPACK-SPIKE N501Y Combo Kit, includes Cat# CVD19-560A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)1 Kit